Trade Summary

3 days ago, Janku Filip, serving as Chief Medical Officer at Monte Rosa Therapeutics, Inc. (GLUE), sold 41,845 shares at $21.08 per share, for a total transaction value of $882,203.48. Following this transaction, Janku Filip now holds 59,992 shares of GLUE.

This sale represents a 41.09% decrease in Janku Filip's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, June 23, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, June 25, 2026 at 4:05 PM ET, 2 days after the trade was made.

Monte Rosa Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.